Discussion: Immunological therapeutics in ovarian cancer

被引：4
作者：
Balkwill, F [1 ]
Schlom, J
Berek, J
Epenetos, A
Bookman, M
Freedman, R
Wilbanks, G
机构：
[1] Imperial Canc Res Fund, Translat Oncol Lab, John Vane Sci Ctr, London, England
[2] London Queen Marys Med Sch, London, England
[3] NCI, Bethesda, MD 20892 USA
[4] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
[5] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Univ S Florida, Tampa, FL 33620 USA
来源：
GYNECOLOGIC ONCOLOGY | 2003年 / 88卷 / 01期
关键词：
D O I：
10.1006/gyno.2002.6696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S110 / S113
页数：4
相关论文
共 50 条
  • [31] FOLATE RECEPTOR-TARGETED THERAPEUTICS FOR OVARIAN CANCER
    Graybill, W. S.
    Coleman, R. L.
    DRUGS OF THE FUTURE, 2016, 41 (02) : 137 - 143
  • [32] EGFR/HER-targeted therapeutics in ovarian cancer
    Wilken, Jason A.
    Badri, Tayf
    Cross, Sarah
    Raji, Rhoda
    Santin, Alessandro D.
    Schwartz, Peter
    Branscum, Adam J.
    Baron, Andre T.
    Sakhitab, Adam I.
    Maihle, Nita J.
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (04) : 447 - 469
  • [33] Iron Takes Center Stage in Cancer Therapeutics: Ferroptosis and Ovarian Cancer
    Torii, Suzy
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 145 : S6 - S6
  • [34] T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
    Christopher A. Klebanoff
    Smita S. Chandran
    Brian M. Baker
    Sergio A. Quezada
    Antoni Ribas
    Nature Reviews Drug Discovery, 2023, 22 : 996 - 1017
  • [35] T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
    Klebanoff, Christopher A.
    Chandran, Smita S.
    Baker, Brian M.
    Quezada, Sergio A.
    Ribas, Antoni
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (12) : 996 - 1017
  • [36] Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer
    Zhou, Min
    Li, Bingshu
    Liu, Jianfeng
    Hong, Li
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 7341 - 7358
  • [37] Immunological parameters as a new lead in the diagnosis of ovarian cancer
    Baert, T.
    Timmerman, D.
    Vergote, I.
    Coosemans, A.
    FACTS VIEWS AND VISION IN OBGYN, 2015, 7 (01) : 67 - 72
  • [38] Diagnostic, prognostic, and immunological roles of CDSN in ovarian cancer
    Zeng, Huan
    Pan, Wei
    Xia, Qiuyi
    Shu, Hong
    Ji, Zhaodong
    HELIYON, 2024, 10 (12)
  • [39] PROSPECTS FOR AN IMMUNOLOGICAL APPROACH TO THERAPY OF OVARIAN-CANCER
    MACLEAN, GD
    LONGENECKER, BM
    CLINICAL IMMUNOTHERAPEUTICS, 1994, 2 (06): : 409 - 414
  • [40] Discussion: Metastasis and angiogenesis in epithelial ovarian cancer
    Kohn, EC
    Fidler, IJ
    Fishman, D
    Jaffe, R
    Liotta, LA
    Van Trappen, P
    Mills, GB
    Trope, C
    GYNECOLOGIC ONCOLOGY, 2003, 88 (01) : S37 - S42
12345